Skip to main content

Dr. Bugsu Ovunc, M.D, PHD

Pediatric Pulmonology (Pediatric Pulmonology Physician)

23600 Telo Ave Ste 130
Torrance, CA 90505

Who else practices at this address →

Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas

Call (310) 833-1334

At a glance

Years since graduation
19
In the NPI registry since
2011

Licensed in California since 2019, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2011Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pediatric Pulmonology Physician primary
    CA license A160694 (first issued 2019; current) · MA license 258379 · NH license 18129

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pediatric Pulmonology per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Payments from drug and device companies

In 2025, 16 companies reported 52 payments worth $1,322 in total to this clinician.

By type
Food and Beverage$1,321

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $104,148 in research payments for these studies, mostly to the institutions running them.

  • A randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT027 compared with PT007 administered as needed in participants 12 to under 18 years of age with as…
    AstraZeneca UK Limited
  • Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
    Sanofi US Services Inc. · Active, not recruiting · NCT06676319
  • Multicentre,Randomised,Double blind,Parallel Group,Placebo controlled,Time to first Asthma Exacerbation Phase tree Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eosinophilic Asthma Dominika
    AstraZeneca UK Limited

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 9, 2025), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1891086088. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.